Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below. Just click on the icons to get to the download page.
Or continue login with
People in the above-60 age group are now eligible to get a second booster dose, but the government s...
Increased awareness among patients for vaccine adoption post-pandemic has made pharmaceutical compan...
Xi told Jokowi that China will promote joint research and development on vaccines and continue to su...
Chinese vaccines helped many countries to recover from the COVID-19 crisis and now many of them, esp...
There should be a clear mechanism to strengthen regional and multilateral cooperation and solidarity...
This year’s G20 Summit presents an opportunity for the international forum to realign its exis...
The COVID-19 outbreak could have decimated China’s reputation. Here's why it didn’t....
Although health diplomacy is instrumental in gaining influence and traction, its international rival...
Epidemiologists have urged the government to bolster third dose rollout and address vaccine shortage...
Amid improved COVID-19 case numbers, a waning appetite for booster shots and a lull in government va...